Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hemochromatosis | 17 | 2012 | 70 | 1.440 |
Why?
|
Epilepsy | 5 | 2021 | 82 | 1.340 |
Why?
|
Depression | 6 | 2024 | 444 | 1.190 |
Why?
|
Influenza, Human | 10 | 2023 | 122 | 1.090 |
Why?
|
Iron Overload | 10 | 2012 | 38 | 0.870 |
Why?
|
Female | 113 | 2024 | 19969 | 0.860 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 7 | 2020 | 27 | 0.840 |
Why?
|
Humans | 130 | 2024 | 32004 | 0.790 |
Why?
|
Anxiety | 6 | 2024 | 190 | 0.760 |
Why?
|
Women's Health | 7 | 2020 | 235 | 0.760 |
Why?
|
Histocompatibility Antigens Class I | 9 | 2010 | 59 | 0.750 |
Why?
|
Infant, Very Low Birth Weight | 7 | 2017 | 49 | 0.710 |
Why?
|
Iron | 10 | 2012 | 116 | 0.700 |
Why?
|
Membrane Proteins | 10 | 2012 | 256 | 0.700 |
Why?
|
Ferritins | 8 | 2010 | 47 | 0.680 |
Why?
|
Male | 94 | 2024 | 19169 | 0.680 |
Why?
|
Adult | 59 | 2024 | 9346 | 0.670 |
Why?
|
Mutation | 10 | 2020 | 489 | 0.610 |
Why?
|
Cognition Disorders | 5 | 2019 | 385 | 0.550 |
Why?
|
Genome-Wide Association Study | 10 | 2022 | 547 | 0.540 |
Why?
|
Dystonic Disorders | 5 | 2020 | 12 | 0.530 |
Why?
|
Diabetes Mellitus, Type 2 | 12 | 2014 | 1428 | 0.530 |
Why?
|
Infant, Newborn | 18 | 2023 | 668 | 0.500 |
Why?
|
Quality of Life | 8 | 2024 | 946 | 0.490 |
Why?
|
Adolescent | 34 | 2018 | 3540 | 0.490 |
Why?
|
African Americans | 15 | 2016 | 1426 | 0.490 |
Why?
|
Influenza Vaccines | 4 | 2023 | 78 | 0.480 |
Why?
|
Influenza A Virus, H1N1 Subtype | 5 | 2016 | 47 | 0.470 |
Why?
|
Middle Aged | 46 | 2020 | 11827 | 0.460 |
Why?
|
Mass Screening | 5 | 2021 | 263 | 0.440 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2010 | 251 | 0.420 |
Why?
|
Diabetes Mellitus | 9 | 2008 | 411 | 0.420 |
Why?
|
North Carolina | 28 | 2016 | 1514 | 0.420 |
Why?
|
Genetic Predisposition to Disease | 10 | 2019 | 835 | 0.410 |
Why?
|
Aged | 42 | 2020 | 10318 | 0.410 |
Why?
|
Continental Population Groups | 6 | 2016 | 237 | 0.400 |
Why?
|
Adrenal Cortex Hormones | 3 | 2017 | 122 | 0.390 |
Why?
|
Rural Population | 10 | 2010 | 274 | 0.380 |
Why?
|
European Continental Ancestry Group | 14 | 2016 | 1166 | 0.380 |
Why?
|
Dementia | 3 | 2019 | 252 | 0.370 |
Why?
|
Cross-Sectional Studies | 15 | 2021 | 1531 | 0.370 |
Why?
|
Glucocorticoids | 4 | 2003 | 147 | 0.370 |
Why?
|
Dexamethasone | 2 | 2001 | 45 | 0.360 |
Why?
|
Bronchopulmonary Dysplasia | 4 | 2002 | 11 | 0.360 |
Why?
|
Psoriasis | 6 | 2005 | 360 | 0.360 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2016 | 92 | 0.360 |
Why?
|
Prospective Studies | 10 | 2021 | 2280 | 0.340 |
Why?
|
Hospitalization | 6 | 2013 | 470 | 0.340 |
Why?
|
Genetic Testing | 6 | 2009 | 96 | 0.320 |
Why?
|
Asthma | 4 | 2003 | 259 | 0.320 |
Why?
|
Anxiety Disorders | 3 | 2021 | 77 | 0.320 |
Why?
|
Infant | 15 | 2023 | 1059 | 0.320 |
Why?
|
Risk Factors | 19 | 2020 | 3872 | 0.320 |
Why?
|
Genotype | 18 | 2014 | 733 | 0.310 |
Why?
|
Child, Preschool | 17 | 2018 | 1268 | 0.310 |
Why?
|
Blood Pressure | 7 | 2022 | 845 | 0.310 |
Why?
|
Child | 21 | 2019 | 2436 | 0.310 |
Why?
|
Estrogen Replacement Therapy | 3 | 2020 | 199 | 0.300 |
Why?
|
Laser Therapy | 3 | 2002 | 55 | 0.290 |
Why?
|
Polymorphism, Single Nucleotide | 10 | 2022 | 1062 | 0.290 |
Why?
|
Genetic Variation | 3 | 2019 | 244 | 0.280 |
Why?
|
United States | 20 | 2020 | 3938 | 0.280 |
Why?
|
Phenotype | 12 | 2016 | 632 | 0.280 |
Why?
|
Genome, Human | 3 | 2019 | 132 | 0.280 |
Why?
|
Ethnic Groups | 8 | 2016 | 476 | 0.280 |
Why?
|
Self Care | 7 | 2016 | 144 | 0.270 |
Why?
|
Pesticides | 5 | 2008 | 199 | 0.270 |
Why?
|
Agriculture | 6 | 2008 | 186 | 0.270 |
Why?
|
Population Surveillance | 5 | 2015 | 124 | 0.270 |
Why?
|
Transferrin | 6 | 2007 | 33 | 0.260 |
Why?
|
Hispanic Americans | 9 | 2016 | 940 | 0.260 |
Why?
|
Health Behavior | 4 | 2017 | 231 | 0.260 |
Why?
|
Dietary Fats | 3 | 2009 | 110 | 0.250 |
Why?
|
Overweight | 2 | 2018 | 279 | 0.250 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2024 | 2 | 0.250 |
Why?
|
Environmental Exposure | 4 | 2008 | 91 | 0.250 |
Why?
|
Disability Evaluation | 2 | 2016 | 240 | 0.240 |
Why?
|
Aged, 80 and over | 17 | 2019 | 3995 | 0.240 |
Why?
|
Mothers | 4 | 2014 | 88 | 0.240 |
Why?
|
Survivors | 2 | 2016 | 164 | 0.240 |
Why?
|
Indians, North American | 8 | 2010 | 109 | 0.230 |
Why?
|
Age of Onset | 4 | 2019 | 94 | 0.230 |
Why?
|
Diabetes Complications | 4 | 2010 | 177 | 0.230 |
Why?
|
Premature Birth | 2 | 2015 | 66 | 0.230 |
Why?
|
Renin-Angiotensin System | 2 | 2016 | 179 | 0.230 |
Why?
|
Reproducibility of Results | 5 | 2021 | 762 | 0.230 |
Why?
|
Geriatric Assessment | 2 | 2016 | 391 | 0.220 |
Why?
|
Ultraviolet Therapy | 3 | 2002 | 40 | 0.220 |
Why?
|
Health Status | 6 | 2019 | 400 | 0.220 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2021 | 97 | 0.210 |
Why?
|
Pre-Eclampsia | 2 | 2014 | 66 | 0.210 |
Why?
|
Hypertension | 3 | 2022 | 959 | 0.210 |
Why?
|
Homozygote | 5 | 2010 | 58 | 0.210 |
Why?
|
Pregnancy | 8 | 2023 | 996 | 0.210 |
Why?
|
Activities of Daily Living | 3 | 2015 | 259 | 0.200 |
Why?
|
Albuminuria | 3 | 2008 | 181 | 0.190 |
Why?
|
Prevalence | 10 | 2018 | 981 | 0.190 |
Why?
|
Dystonia | 3 | 2019 | 12 | 0.190 |
Why?
|
Young Adult | 10 | 2018 | 2638 | 0.190 |
Why?
|
Blood Glucose | 3 | 2014 | 494 | 0.190 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 2019 | 15 | 0.190 |
Why?
|
Obesity | 4 | 2018 | 1176 | 0.190 |
Why?
|
Birth Weight | 4 | 2017 | 47 | 0.190 |
Why?
|
Retinopathy of Prematurity | 1 | 2001 | 8 | 0.190 |
Why?
|
Dysarthria | 1 | 2020 | 3 | 0.190 |
Why?
|
Smoking | 2 | 2017 | 496 | 0.190 |
Why?
|
Speech | 1 | 2020 | 9 | 0.190 |
Why?
|
Dysphonia | 1 | 2020 | 8 | 0.180 |
Why?
|
Psychiatry | 1 | 2020 | 19 | 0.180 |
Why?
|
Prostaglandin D2 | 1 | 2000 | 4 | 0.180 |
Why?
|
Housing | 3 | 2006 | 65 | 0.180 |
Why?
|
Ventricular Dysfunction | 1 | 2000 | 4 | 0.180 |
Why?
|
Biomedical Research | 2 | 2020 | 156 | 0.180 |
Why?
|
Vitamin A | 1 | 2000 | 21 | 0.180 |
Why?
|
Transposition of Great Vessels | 1 | 2000 | 3 | 0.180 |
Why?
|
Aging | 3 | 2016 | 946 | 0.180 |
Why?
|
Dinoprostone | 1 | 2000 | 31 | 0.180 |
Why?
|
Cohort Studies | 8 | 2018 | 1821 | 0.180 |
Why?
|
Polymorphism, Genetic | 2 | 2013 | 184 | 0.170 |
Why?
|
Respiratory Tract Infections | 2 | 2018 | 40 | 0.170 |
Why?
|
Hemiplegia | 1 | 2019 | 13 | 0.170 |
Why?
|
African Continental Ancestry Group | 6 | 2010 | 363 | 0.170 |
Why?
|
Lactation | 1 | 1999 | 16 | 0.170 |
Why?
|
Milk | 1 | 1999 | 16 | 0.170 |
Why?
|
Agricultural Workers' Diseases | 2 | 2006 | 85 | 0.170 |
Why?
|
Resilience, Psychological | 1 | 2019 | 18 | 0.170 |
Why?
|
Apolipoprotein E4 | 1 | 2019 | 63 | 0.170 |
Why?
|
Patient Participation | 1 | 2020 | 82 | 0.160 |
Why?
|
Neoplasms | 2 | 2016 | 724 | 0.160 |
Why?
|
Ataxia | 2 | 2016 | 8 | 0.160 |
Why?
|
Body Weight | 2 | 2018 | 310 | 0.160 |
Why?
|
Uric Acid | 2 | 2017 | 27 | 0.160 |
Why?
|
Primary Health Care | 4 | 2005 | 227 | 0.160 |
Why?
|
Parkinsonian Disorders | 2 | 2019 | 9 | 0.160 |
Why?
|
Hormone Replacement Therapy | 1 | 2019 | 91 | 0.160 |
Why?
|
Logistic Models | 6 | 2019 | 781 | 0.160 |
Why?
|
Fractures, Bone | 2 | 2020 | 148 | 0.160 |
Why?
|
Cognition | 2 | 2019 | 555 | 0.160 |
Why?
|
Rural Health | 3 | 2007 | 44 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 510 | 0.150 |
Why?
|
Cardiovascular Diseases | 3 | 2020 | 1126 | 0.150 |
Why?
|
Emergency Service, Hospital | 4 | 2016 | 474 | 0.150 |
Why?
|
Incidence | 5 | 2020 | 1198 | 0.150 |
Why?
|
Multivariate Analysis | 6 | 2018 | 687 | 0.150 |
Why?
|
Metabolic Diseases | 1 | 2017 | 18 | 0.150 |
Why?
|
Sex Factors | 5 | 2016 | 662 | 0.150 |
Why?
|
Anti-Inflammatory Agents | 2 | 2003 | 99 | 0.150 |
Why?
|
Depressive Disorder | 2 | 2010 | 75 | 0.140 |
Why?
|
Interviews as Topic | 8 | 2008 | 263 | 0.140 |
Why?
|
Erythropoiesis | 1 | 2016 | 7 | 0.140 |
Why?
|
Dermatomyositis | 2 | 2007 | 19 | 0.140 |
Why?
|
Erythrocytes | 1 | 2016 | 48 | 0.140 |
Why?
|
Caffeine | 1 | 2016 | 29 | 0.140 |
Why?
|
Genetic Loci | 3 | 2012 | 146 | 0.140 |
Why?
|
Attitude to Health | 2 | 2017 | 165 | 0.140 |
Why?
|
Heart Rate | 2 | 2016 | 331 | 0.140 |
Why?
|
Vaccination | 2 | 2023 | 138 | 0.140 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 68 | 0.140 |
Why?
|
Age Distribution | 2 | 2014 | 206 | 0.140 |
Why?
|
Memory Disorders | 1 | 2016 | 54 | 0.140 |
Why?
|
Pair Bond | 1 | 2015 | 2 | 0.130 |
Why?
|
Polysomnography | 1 | 2016 | 40 | 0.130 |
Why?
|
Melanoma | 2 | 2001 | 164 | 0.130 |
Why?
|
Animals, Laboratory | 1 | 2015 | 4 | 0.130 |
Why?
|
Tennessee | 6 | 2013 | 101 | 0.130 |
Why?
|
Housing, Animal | 1 | 2015 | 23 | 0.130 |
Why?
|
Immunization Programs | 2 | 2013 | 26 | 0.130 |
Why?
|
Infant, Premature, Diseases | 2 | 2012 | 25 | 0.130 |
Why?
|
Automobile Driving | 1 | 2015 | 23 | 0.130 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2016 | 58 | 0.130 |
Why?
|
Sleep | 1 | 2016 | 92 | 0.130 |
Why?
|
Health Surveys | 5 | 2016 | 197 | 0.130 |
Why?
|
Clinical Medicine | 1 | 2015 | 12 | 0.130 |
Why?
|
Patient Dropouts | 1 | 2015 | 28 | 0.130 |
Why?
|
Child Welfare | 2 | 2006 | 21 | 0.130 |
Why?
|
Alzheimer Disease | 1 | 2019 | 327 | 0.120 |
Why?
|
Infant, Premature | 4 | 2016 | 68 | 0.120 |
Why?
|
Skin Neoplasms | 2 | 2001 | 214 | 0.120 |
Why?
|
Mutant Chimeric Proteins | 1 | 2014 | 5 | 0.120 |
Why?
|
HLA-B27 Antigen | 1 | 2014 | 8 | 0.120 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2014 | 9 | 0.120 |
Why?
|
HMGA2 Protein | 1 | 2014 | 13 | 0.120 |
Why?
|
Smoking Cessation | 1 | 2017 | 197 | 0.120 |
Why?
|
Homeostasis | 1 | 2014 | 132 | 0.120 |
Why?
|
Retrospective Studies | 8 | 2018 | 3523 | 0.120 |
Why?
|
Follow-Up Studies | 5 | 2019 | 2277 | 0.120 |
Why?
|
Heart Failure | 1 | 2000 | 634 | 0.120 |
Why?
|
Molecular Epidemiology | 2 | 2011 | 20 | 0.120 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2013 | 27 | 0.120 |
Why?
|
Decision Support Techniques | 1 | 2015 | 128 | 0.120 |
Why?
|
Databases, Genetic | 1 | 2013 | 37 | 0.110 |
Why?
|
Models, Theoretical | 1 | 2015 | 136 | 0.110 |
Why?
|
Pharmacogenetics | 1 | 2013 | 29 | 0.110 |
Why?
|
Dermatitis, Occupational | 1 | 2003 | 10 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2008 | 353 | 0.110 |
Why?
|
Organometallic Compounds | 1 | 2003 | 23 | 0.110 |
Why?
|
Women's Health Services | 1 | 2013 | 11 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2013 | 36 | 0.110 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2003 | 24 | 0.110 |
Why?
|
Patient Compliance | 1 | 2015 | 225 | 0.110 |
Why?
|
Pyridines | 1 | 2003 | 76 | 0.110 |
Why?
|
Zinc | 1 | 2003 | 32 | 0.110 |
Why?
|
Clobetasol | 1 | 2003 | 26 | 0.110 |
Why?
|
Severity of Illness Index | 4 | 2007 | 882 | 0.110 |
Why?
|
Lipectomy | 1 | 2002 | 9 | 0.110 |
Why?
|
Dermatology | 2 | 2002 | 163 | 0.110 |
Why?
|
Antiviral Agents | 1 | 2013 | 108 | 0.110 |
Why?
|
Patient Acceptance of Health Care | 2 | 2005 | 170 | 0.110 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2002 | 27 | 0.110 |
Why?
|
Whooping Cough | 1 | 2012 | 11 | 0.100 |
Why?
|
Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2012 | 8 | 0.100 |
Why?
|
Liver Diseases | 3 | 2008 | 70 | 0.100 |
Why?
|
Odds Ratio | 4 | 2019 | 474 | 0.100 |
Why?
|
Platelet Count | 1 | 2012 | 23 | 0.100 |
Why?
|
Mood Disorders | 1 | 2012 | 21 | 0.100 |
Why?
|
Rotavirus Vaccines | 1 | 2012 | 6 | 0.100 |
Why?
|
Rotavirus Infections | 1 | 2012 | 9 | 0.100 |
Why?
|
Occupational Exposure | 2 | 2006 | 232 | 0.100 |
Why?
|
Asian Continental Ancestry Group | 5 | 2012 | 108 | 0.100 |
Why?
|
Blood Platelets | 1 | 2012 | 39 | 0.100 |
Why?
|
Dermatologic Agents | 2 | 2002 | 229 | 0.100 |
Why?
|
Estrogens | 1 | 2013 | 180 | 0.100 |
Why?
|
Leukocyte Count | 1 | 2011 | 49 | 0.100 |
Why?
|
Postmenopause | 3 | 2020 | 430 | 0.100 |
Why?
|
Family | 2 | 2010 | 117 | 0.100 |
Why?
|
Memory | 1 | 2013 | 190 | 0.100 |
Why?
|
Phototherapy | 1 | 2001 | 52 | 0.100 |
Why?
|
Mental Disorders | 1 | 2012 | 121 | 0.100 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2011 | 2 | 0.100 |
Why?
|
Adiposity | 1 | 2012 | 198 | 0.100 |
Why?
|
Lod Score | 4 | 2007 | 72 | 0.090 |
Why?
|
Body Mass Index | 6 | 2016 | 923 | 0.090 |
Why?
|
Time Factors | 5 | 2016 | 2152 | 0.090 |
Why?
|
Alcoholism | 1 | 2012 | 101 | 0.090 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2000 | 10 | 0.090 |
Why?
|
Creatinine | 2 | 2008 | 195 | 0.090 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2011 | 32 | 0.090 |
Why?
|
Body Composition | 3 | 2017 | 397 | 0.090 |
Why?
|
Intention to Treat Analysis | 2 | 2020 | 28 | 0.090 |
Why?
|
Quality of Health Care | 1 | 2001 | 147 | 0.090 |
Why?
|
Hemoglobin C | 1 | 2010 | 2 | 0.090 |
Why?
|
Oceanic Ancestry Group | 2 | 2007 | 7 | 0.090 |
Why?
|
Sickle Cell Trait | 1 | 2010 | 14 | 0.090 |
Why?
|
Transients and Migrants | 1 | 2003 | 290 | 0.090 |
Why?
|
Family Health | 2 | 2007 | 76 | 0.090 |
Why?
|
Pneumococcal Infections | 1 | 2010 | 31 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2002 | 240 | 0.090 |
Why?
|
Mutation, Missense | 1 | 2010 | 50 | 0.090 |
Why?
|
Arteries | 1 | 2010 | 67 | 0.090 |
Why?
|
Age Factors | 5 | 2007 | 1189 | 0.090 |
Why?
|
Chromosome Mapping | 3 | 2003 | 193 | 0.090 |
Why?
|
Ambulatory Care Facilities | 2 | 2020 | 83 | 0.090 |
Why?
|
Gene Frequency | 5 | 2007 | 220 | 0.090 |
Why?
|
Diet, Fat-Restricted | 1 | 2009 | 31 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2000 | 108 | 0.080 |
Why?
|
Anti-Bacterial Agents | 2 | 2000 | 323 | 0.080 |
Why?
|
Treatment Outcome | 6 | 2010 | 3313 | 0.080 |
Why?
|
Clinical Competence | 1 | 2001 | 333 | 0.080 |
Why?
|
Medical History Taking | 1 | 2008 | 37 | 0.080 |
Why?
|
Prognosis | 3 | 2017 | 1503 | 0.080 |
Why?
|
Apolipoproteins B | 1 | 2007 | 46 | 0.080 |
Why?
|
Autoimmunity | 1 | 2007 | 32 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2011 | 38 | 0.070 |
Why?
|
Genetic Markers | 3 | 2001 | 124 | 0.070 |
Why?
|
Regression Analysis | 3 | 2008 | 293 | 0.070 |
Why?
|
RNA Splice Sites | 1 | 2007 | 1 | 0.070 |
Why?
|
DNA | 1 | 2008 | 226 | 0.070 |
Why?
|
Religion and Psychology | 1 | 2007 | 7 | 0.070 |
Why?
|
Gestational Age | 2 | 2002 | 120 | 0.070 |
Why?
|
Cation Transport Proteins | 1 | 2007 | 24 | 0.070 |
Why?
|
Ownership | 1 | 2007 | 15 | 0.070 |
Why?
|
Preventive Medicine | 1 | 2007 | 9 | 0.070 |
Why?
|
Equipment and Supplies | 1 | 2007 | 16 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2007 | 173 | 0.070 |
Why?
|
Cultural Diversity | 1 | 2007 | 21 | 0.070 |
Why?
|
Fetal Organ Maturity | 2 | 2016 | 7 | 0.070 |
Why?
|
Movement Disorders | 2 | 2019 | 26 | 0.070 |
Why?
|
Asian Americans | 1 | 2007 | 97 | 0.070 |
Why?
|
Cholesterol | 2 | 2019 | 252 | 0.070 |
Why?
|
California | 3 | 2012 | 62 | 0.070 |
Why?
|
Quantitative Trait Loci | 1 | 2007 | 140 | 0.070 |
Why?
|
Heterozygote | 2 | 2019 | 59 | 0.070 |
Why?
|
Patient Education as Topic | 2 | 2005 | 271 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2003 | 525 | 0.070 |
Why?
|
Medicaid | 2 | 2000 | 94 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2007 | 122 | 0.070 |
Why?
|
Models, Statistical | 1 | 2006 | 173 | 0.060 |
Why?
|
Health Promotion | 1 | 2008 | 246 | 0.060 |
Why?
|
Administration, Topical | 3 | 2003 | 140 | 0.060 |
Why?
|
Complementary Therapies | 1 | 2006 | 80 | 0.060 |
Why?
|
Health Services for the Aged | 1 | 2005 | 25 | 0.060 |
Why?
|
Energy Intake | 3 | 2000 | 128 | 0.060 |
Why?
|
Neuropsychological Tests | 2 | 2019 | 371 | 0.060 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2005 | 44 | 0.060 |
Why?
|
Specialization | 1 | 2005 | 31 | 0.060 |
Why?
|
Diabetic Foot | 1 | 2005 | 19 | 0.060 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2005 | 27 | 0.060 |
Why?
|
Linkage Disequilibrium | 2 | 2016 | 185 | 0.060 |
Why?
|
Rural Health Services | 1 | 2005 | 30 | 0.060 |
Why?
|
Medicine | 1 | 2005 | 38 | 0.060 |
Why?
|
Catheterization, Central Venous | 1 | 2005 | 62 | 0.060 |
Why?
|
Single-Blind Method | 1 | 2024 | 203 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 756 | 0.060 |
Why?
|
Environmental Monitoring | 1 | 2004 | 28 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2016 | 766 | 0.060 |
Why?
|
Accidental Falls | 1 | 2006 | 221 | 0.060 |
Why?
|
Acute Disease | 2 | 2018 | 252 | 0.060 |
Why?
|
Administration, Inhalation | 2 | 2000 | 54 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2016 | 120 | 0.060 |
Why?
|
Medicare | 1 | 2005 | 207 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2011 | 583 | 0.050 |
Why?
|
Hemagglutinins | 1 | 2023 | 4 | 0.050 |
Why?
|
Outpatient Clinics, Hospital | 2 | 2013 | 16 | 0.050 |
Why?
|
Seasons | 2 | 2013 | 87 | 0.050 |
Why?
|
Antibodies, Viral | 1 | 2023 | 58 | 0.050 |
Why?
|
Alleles | 2 | 2016 | 248 | 0.050 |
Why?
|
Communication | 1 | 2004 | 142 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2005 | 242 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2023 | 122 | 0.050 |
Why?
|
Immunization Schedule | 2 | 2012 | 26 | 0.050 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 1992 | 2 | 0.050 |
Why?
|
Recombination, Genetic | 1 | 1992 | 22 | 0.050 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 1992 | 9 | 0.050 |
Why?
|
Lasers | 2 | 2002 | 21 | 0.050 |
Why?
|
Risk Assessment | 2 | 2006 | 1431 | 0.050 |
Why?
|
Genomics | 1 | 2022 | 85 | 0.050 |
Why?
|
Receptors, Cell Surface | 2 | 2012 | 70 | 0.050 |
Why?
|
Virginia | 3 | 2008 | 63 | 0.050 |
Why?
|
Genetic Heterogeneity | 1 | 2001 | 14 | 0.050 |
Why?
|
Socioeconomic Factors | 3 | 2010 | 422 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 461 | 0.050 |
Why?
|
Africa | 2 | 2016 | 27 | 0.050 |
Why?
|
Animals | 3 | 2016 | 7542 | 0.050 |
Why?
|
Demography | 2 | 2015 | 109 | 0.050 |
Why?
|
Europe | 2 | 2016 | 82 | 0.050 |
Why?
|
Lactates | 1 | 1990 | 2 | 0.050 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2000 | 4 | 0.050 |
Why?
|
Retinol-Binding Proteins | 1 | 2000 | 3 | 0.050 |
Why?
|
Research Design | 1 | 2003 | 313 | 0.050 |
Why?
|
Dietary Carbohydrates | 1 | 1990 | 22 | 0.050 |
Why?
|
Gallbladder Diseases | 1 | 2020 | 7 | 0.050 |
Why?
|
Allergens | 1 | 2000 | 15 | 0.050 |
Why?
|
Patient Preference | 1 | 2020 | 47 | 0.050 |
Why?
|
Drug Utilization Review | 1 | 2000 | 17 | 0.050 |
Why?
|
Parents | 2 | 2012 | 147 | 0.050 |
Why?
|
Echocardiography, Doppler | 1 | 2000 | 45 | 0.050 |
Why?
|
Cross-Over Studies | 1 | 2000 | 95 | 0.050 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2000 | 59 | 0.040 |
Why?
|
Bronchoscopy | 1 | 2000 | 47 | 0.040 |
Why?
|
Exercise | 1 | 2006 | 672 | 0.040 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2020 | 102 | 0.040 |
Why?
|
Data Collection | 2 | 2008 | 180 | 0.040 |
Why?
|
Anti-Asthmatic Agents | 1 | 2000 | 39 | 0.040 |
Why?
|
Leptin | 1 | 2000 | 71 | 0.040 |
Why?
|
Anemia, Sickle Cell | 1 | 2000 | 45 | 0.040 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 2020 | 140 | 0.040 |
Why?
|
Freezing | 1 | 1999 | 4 | 0.040 |
Why?
|
Centrifugation | 1 | 1999 | 3 | 0.040 |
Why?
|
Nutritive Value | 1 | 1999 | 10 | 0.040 |
Why?
|
Antidepressive Agents | 1 | 2020 | 74 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2016 | 463 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2020 | 141 | 0.040 |
Why?
|
Catechol O-Methyltransferase | 1 | 2019 | 14 | 0.040 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2019 | 10 | 0.040 |
Why?
|
Recombinases | 1 | 2019 | 2 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2019 | 30 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 35 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2019 | 37 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2000 | 147 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 73 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2019 | 95 | 0.040 |
Why?
|
Lung | 1 | 2000 | 247 | 0.040 |
Why?
|
Atrial Natriuretic Factor | 1 | 1988 | 10 | 0.040 |
Why?
|
Insulin | 1 | 1990 | 368 | 0.040 |
Why?
|
Canada | 2 | 2008 | 56 | 0.040 |
Why?
|
Ascites | 1 | 1988 | 16 | 0.040 |
Why?
|
North America | 2 | 2009 | 32 | 0.040 |
Why?
|
Lipids | 1 | 1999 | 232 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 1988 | 82 | 0.040 |
Why?
|
Pedigree | 2 | 2012 | 140 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 2017 | 33 | 0.040 |
Why?
|
Far East | 1 | 2016 | 3 | 0.040 |
Why?
|
Zebrafish | 1 | 2016 | 23 | 0.040 |
Why?
|
Safety | 2 | 2008 | 78 | 0.040 |
Why?
|
Sex Distribution | 2 | 2008 | 191 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2016 | 80 | 0.030 |
Why?
|
Arthritis | 2 | 2008 | 40 | 0.030 |
Why?
|
Snoring | 1 | 2016 | 10 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 2016 | 43 | 0.030 |
Why?
|
Life Change Events | 1 | 2016 | 21 | 0.030 |
Why?
|
Cerebellum | 1 | 2016 | 26 | 0.030 |
Why?
|
Atrophy | 1 | 2016 | 46 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2017 | 238 | 0.030 |
Why?
|
Twins | 1 | 1986 | 7 | 0.030 |
Why?
|
Linear Models | 1 | 2017 | 448 | 0.030 |
Why?
|
Oximetry | 1 | 2016 | 31 | 0.030 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 36 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2016 | 75 | 0.030 |
Why?
|
Body Height | 1 | 1986 | 34 | 0.030 |
Why?
|
Renin | 1 | 2016 | 109 | 0.030 |
Why?
|
Proxy | 1 | 2015 | 9 | 0.030 |
Why?
|
Psychological Tests | 1 | 2015 | 35 | 0.030 |
Why?
|
Heart Diseases | 2 | 2008 | 116 | 0.030 |
Why?
|
Frail Elderly | 1 | 2016 | 69 | 0.030 |
Why?
|
Term Birth | 1 | 2015 | 5 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 495 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2016 | 136 | 0.030 |
Why?
|
Angiotensin II | 1 | 2016 | 244 | 0.030 |
Why?
|
Cross-Cultural Comparison | 2 | 2005 | 26 | 0.030 |
Why?
|
Systole | 1 | 2015 | 99 | 0.030 |
Why?
|
Genome | 1 | 2014 | 38 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2016 | 294 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2015 | 73 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2015 | 43 | 0.030 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2014 | 23 | 0.030 |
Why?
|
Influenza B virus | 1 | 2014 | 20 | 0.030 |
Why?
|
Angiotensin I | 1 | 2016 | 241 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2015 | 305 | 0.030 |
Why?
|
Aldosterone | 1 | 2014 | 26 | 0.030 |
Why?
|
Computer Simulation | 1 | 2015 | 220 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2016 | 399 | 0.030 |
Why?
|
Mexico | 1 | 2003 | 71 | 0.030 |
Why?
|
Life Style | 1 | 2016 | 408 | 0.030 |
Why?
|
Databases, Factual | 1 | 2014 | 353 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2003 | 21 | 0.030 |
Why?
|
Genetics, Population | 1 | 2003 | 32 | 0.030 |
Why?
|
New York | 1 | 2013 | 21 | 0.030 |
Why?
|
Hyaline Membrane Disease | 1 | 2002 | 1 | 0.030 |
Why?
|
Skin Absorption | 1 | 2002 | 9 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 198 | 0.030 |
Why?
|
Apgar Score | 1 | 2002 | 8 | 0.030 |
Why?
|
Utilization Review | 1 | 2013 | 17 | 0.030 |
Why?
|
Intensive Care, Neonatal | 1 | 2002 | 9 | 0.030 |
Why?
|
Surgicenters | 1 | 2002 | 3 | 0.030 |
Why?
|
Solutions | 1 | 2002 | 36 | 0.030 |
Why?
|
Ohio | 1 | 2013 | 58 | 0.030 |
Why?
|
Physicians' Offices | 1 | 2002 | 10 | 0.030 |
Why?
|
Models, Genetic | 2 | 2007 | 94 | 0.030 |
Why?
|
Infant Mortality | 1 | 2002 | 22 | 0.030 |
Why?
|
New York City | 1 | 2002 | 14 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2012 | 3 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2012 | 18 | 0.030 |
Why?
|
Postoperative Period | 1 | 2002 | 97 | 0.030 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2012 | 8 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 288 | 0.030 |
Why?
|
Maryland | 1 | 2002 | 28 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2012 | 20 | 0.030 |
Why?
|
Precipitating Factors | 1 | 2012 | 2 | 0.030 |
Why?
|
Focus Groups | 1 | 2002 | 113 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 263 | 0.030 |
Why?
|
Pennsylvania | 1 | 2002 | 83 | 0.030 |
Why?
|
Proteoglycans | 1 | 2012 | 32 | 0.030 |
Why?
|
Postpartum Period | 1 | 2012 | 33 | 0.030 |
Why?
|
Gastroenteritis | 1 | 2012 | 12 | 0.030 |
Why?
|
Platelet Aggregation | 1 | 2012 | 21 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2012 | 108 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2002 | 84 | 0.030 |
Why?
|
Databases as Topic | 1 | 2001 | 22 | 0.030 |
Why?
|
Hot Temperature | 1 | 2012 | 71 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2001 | 43 | 0.030 |
Why?
|
Cyclosporine | 1 | 2001 | 49 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2001 | 30 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2001 | 40 | 0.020 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2011 | 10 | 0.020 |
Why?
|
Duffy Blood-Group System | 1 | 2011 | 4 | 0.020 |
Why?
|
Program Evaluation | 1 | 2012 | 186 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2002 | 319 | 0.020 |
Why?
|
Chemokine CXCL2 | 1 | 2011 | 10 | 0.020 |
Why?
|
Receptors, Nicotinic | 1 | 2012 | 59 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2011 | 31 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2005 | 875 | 0.020 |
Why?
|
Artifacts | 1 | 2011 | 39 | 0.020 |
Why?
|
DNA Replication | 1 | 2011 | 34 | 0.020 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2011 | 9 | 0.020 |
Why?
|
Recurrence | 1 | 2002 | 265 | 0.020 |
Why?
|
Heart Defects, Congenital | 1 | 2000 | 31 | 0.020 |
Why?
|
Cardiac Output, Low | 1 | 2000 | 10 | 0.020 |
Why?
|
Pulsatile Flow | 1 | 2010 | 26 | 0.020 |
Why?
|
Elasticity | 1 | 2010 | 36 | 0.020 |
Why?
|
Myocarditis | 1 | 2000 | 7 | 0.020 |
Why?
|
Streptococcus pneumoniae | 1 | 2010 | 40 | 0.020 |
Why?
|
Risk | 1 | 2011 | 320 | 0.020 |
Why?
|
Arm | 1 | 2010 | 35 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2010 | 77 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2001 | 246 | 0.020 |
Why?
|
Leg | 1 | 2010 | 65 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 1328 | 0.020 |
Why?
|
Brachial Artery | 1 | 2010 | 69 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2012 | 249 | 0.020 |
Why?
|
Infant, Low Birth Weight | 1 | 2008 | 11 | 0.020 |
Why?
|
Nutritional Sciences | 1 | 2008 | 9 | 0.020 |
Why?
|
Kentucky | 1 | 2007 | 15 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2007 | 24 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2007 | 48 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 407 | 0.020 |
Why?
|
Hemosiderosis | 1 | 2007 | 2 | 0.020 |
Why?
|
Vietnam | 1 | 2007 | 24 | 0.020 |
Why?
|
Protestantism | 1 | 2007 | 7 | 0.020 |
Why?
|
Point Mutation | 1 | 2007 | 28 | 0.020 |
Why?
|
Health Education | 1 | 2008 | 157 | 0.020 |
Why?
|
Laundering | 1 | 2006 | 4 | 0.020 |
Why?
|
Up-Regulation | 1 | 2007 | 189 | 0.020 |
Why?
|
Baths | 1 | 2006 | 8 | 0.020 |
Why?
|
Attitude | 1 | 2006 | 40 | 0.020 |
Why?
|
Religion | 1 | 2006 | 32 | 0.020 |
Why?
|
Family Characteristics | 1 | 2006 | 36 | 0.020 |
Why?
|
Dermatitis | 1 | 2005 | 21 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2008 | 894 | 0.020 |
Why?
|
Comorbidity | 1 | 2007 | 565 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2007 | 138 | 0.020 |
Why?
|
Confidentiality | 1 | 2005 | 29 | 0.020 |
Why?
|
Pruritus | 1 | 2005 | 47 | 0.020 |
Why?
|
Risk-Taking | 1 | 2006 | 93 | 0.020 |
Why?
|
Social Support | 1 | 2007 | 181 | 0.020 |
Why?
|
American Native Continental Ancestry Group | 1 | 2005 | 13 | 0.020 |
Why?
|
Geography | 1 | 2005 | 34 | 0.020 |
Why?
|
Thrombosis | 1 | 2005 | 73 | 0.020 |
Why?
|
Educational Status | 1 | 2005 | 179 | 0.010 |
Why?
|
Poverty | 1 | 2005 | 111 | 0.010 |
Why?
|
Communication Barriers | 1 | 2004 | 22 | 0.010 |
Why?
|
Language | 1 | 2004 | 42 | 0.010 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2003 | 8 | 0.010 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2003 | 13 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2005 | 181 | 0.010 |
Why?
|
Genetic Counseling | 1 | 2003 | 8 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1992 | 44 | 0.010 |
Why?
|
Chromosomes, Human | 1 | 2001 | 10 | 0.010 |
Why?
|
Matched-Pair Analysis | 1 | 2001 | 12 | 0.010 |
Why?
|
Nuclear Family | 1 | 2001 | 15 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1992 | 109 | 0.010 |
Why?
|
Patient Selection | 1 | 2003 | 277 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 359 | 0.010 |
Why?
|
Theophylline | 1 | 2000 | 4 | 0.010 |
Why?
|
Glucose Tolerance Test | 1 | 1990 | 126 | 0.010 |
Why?
|
Lactic Acid | 1 | 1990 | 53 | 0.010 |
Why?
|
Basal Metabolism | 1 | 2000 | 9 | 0.010 |
Why?
|
Adrenergic beta-Agonists | 1 | 2000 | 30 | 0.010 |
Why?
|
Health Resources | 1 | 2000 | 32 | 0.010 |
Why?
|
Bronchodilator Agents | 1 | 2000 | 49 | 0.010 |
Why?
|
Fasting | 1 | 2000 | 95 | 0.010 |
Why?
|
Administration, Oral | 1 | 2000 | 186 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2000 | 119 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2000 | 173 | 0.010 |
Why?
|
Chronic Disease | 1 | 2000 | 405 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1988 | 25 | 0.010 |
Why?
|
Diet | 1 | 2000 | 391 | 0.010 |
Why?
|